The VWR Foundation Celebrates Five Years of Supporting Science
December 9, 2014
RADNOR, Pa. -- The VWR Charitable Foundation, dedicated to giving back to the science community, is celebrating five years of operations. Since 2009, the Foundation has donated more than $1.13 million to more than 75 organizations and programs around the globe. In honor of the Foundation's five year milestone, VWR Corporation is donating $250,000 to [...]
December 9, 2014
SANTA CLARA, Calif. -- eBioscience, an Affymetrix (Nasdaq:AFFX) business, announces the availability of PrimeFlow™ RNA Assay, the first and only flow cytometry assay capable of simultaneous detection of RNA and protein within millions of cells at single-cell resolution. Current flow cytometry applications are limited to antibody-based interrogation of cell surface and intracellular proteins. With the [...]
ZEISS Sublicenses Lattice Light Sheet Microscopy to Intelligent Imaging Innovations
December 8, 2014
JENA/Germany -- ZEISS announces the sublicensing of Lattice light sheet microscopy, also called Bessel beam plane illumination microscopy, to Intelligent Imaging Innovations (3i). ZEISS and the Howard Hughes Medical Institute’s Janelia Research Campus had signed an exclusive license agreement for the commercialization of Lattice light sheet microscopy earlier this year. By granting the exclusive sublicense [...]
December 8, 2014
Cambridge, UK -- Horizon Discovery Group plc (LSE:HZD) (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced that its Bioproduction division has shipped its first commercially available engineered CHO cell line for use in manufacturing of therapeutic antibodies. Horizon’s innovative licensing model brings these cutting [...]
December 8, 2014
WILMINGTON, Mass.–– Kapa Biosystems, Inc. today announced that they have expanded their partnership with Roche NimbleGen to include new, optimized, RNA sample-preparation methods for targeted RNA next-generation sequencing (NGS) applications. Kapa Biosystems will custom manufacture versions of its KAPA Stranded RNA-Seq Kits for Roche NimbleGen to distribute with its recently launched SeqCap RNA Target Enrichment [...]
Sigma-Aldrich® Again Named Top Company for Strengthening Communities through Science
December 8, 2014
ST. LOUIS -- Sigma-Aldrich Corporation (Nasdaq: SIAL) was named today to The Civic 50, an annual initiative that recognizes leading community-minded companies in the U.S. Conducted by Points of Light, the largest organization in the world dedicated to volunteer service, and supported by Bloomberg LP, The Civic 50 honors forward-thinking businesses that are strengthening their [...]
Studying dissolved gases in aqueous solution
December 8, 2014
Hiden Analytical present the HPR-40 mass spectrometer series, engineered specifically for monitoring dissolved gaseous content in aqueous solutions. All systems feature a media interface with semi-permeable membrane to enrich the transition of gases and vapours and simultaneously inhibit the transfer of water vapour. Applications include diverse areas of microbiological study including fermentation culture analysis, biofuel [...]
December 8, 2014
Madrid, Spain and Heidelberg, Germany -– SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that it has signed an initial distribution agreement for its first proprietary product with German BioCat GmbH. With this agreement, SYGNIS grants BioCat non-exclusive rights to promote, market, sell, and support TruePrime™ Single Cell WGA kit for the DNA [...]
Neogen acquires assets of its Chinese distributor
December 8, 2014
LANSING, Mich. -— Neogen Corporation (Nasdaq: NEOG) announced today that it has acquired the food safety and veterinary genomic assets of its Chinese distributor, Beijing Anapure BioScientific Co., Ltd. (Anapure). Anapure has been a distributor of Neogen’s food safety products for more than 10 years, and has also offered Neogen’s veterinary genomic services in recent [...]
Organovo Appoints Dr. Kirk Malloy to Board of Directors
December 8, 2014
SAN DIEGO -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, announced today Kirk D. Malloy, Ph.D. has been appointed to the Company's Board of Directors. Dr. Malloy has held management and executive leadership positions in rapidly growing life science and diagnostics companies for 18 [...]
